Medical devices have outpaced pharmaceutical companies in terms of raising investment dollars from venture capitalist, according to the BioEnterprise (Cleveland) Midwest Venture Investment Report.

Boston Scientific (Natick, Massachusetts) has received FDA 510(k) clearance for a next-generation 3-D cardiac mapping and navigation system designed to improve clarity, efficiency, and physician confidence during catheter ablations and electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.